130 related articles for article (PubMed ID: 1930288)
1. Two-step inactivation of bee venom phospholipase A2 by scalaradial.
de Carvalho MS; Jacobs RS
Biochem Pharmacol; 1991 Sep; 42(8):1621-6. PubMed ID: 1930288
[TBL] [Abstract][Full Text] [Related]
2. Scalaradial, a dialdehyde-containing marine metabolite that causes an unexpected noncovalent PLA2 Inactivation.
Monti MC; Casapullo A; Cavasotto CN; Napolitano A; Riccio R
Chembiochem; 2007 Sep; 8(13):1585-91. PubMed ID: 17691073
[TBL] [Abstract][Full Text] [Related]
3. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
[TBL] [Abstract][Full Text] [Related]
4. Molecular pharmacology of manoalide. Inactivation of bee venom phospholipase A2.
Glaser KB; Jacobs RS
Biochem Pharmacol; 1986 Feb; 35(3):449-53. PubMed ID: 3947381
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of phospholipase A2 by manoalide. Localization of the manoalide binding site on bee venom phospholipase A2.
Glaser KB; Vedvick TS; Jacobs RS
Biochem Pharmacol; 1988 Oct; 37(19):3639-46. PubMed ID: 3178877
[TBL] [Abstract][Full Text] [Related]
6. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.
Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP
Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196
[TBL] [Abstract][Full Text] [Related]
7. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function.
Barnette MS; Rush J; Marshall LA; Foley JJ; Schmidt DB; Sarau HM
Biochem Pharmacol; 1994 Apr; 47(9):1661-7. PubMed ID: 8185681
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of phospholipase A2 activities and some inflammatory responses by the marine product ircinin.
Cholbi R; Ferrándiz ML; Terencio MC; De Rosa S; Alcaraz MJ; Payá M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):677-83. PubMed ID: 8938669
[TBL] [Abstract][Full Text] [Related]
9. Interfacial recognition by bee venom phospholipase A2: insights into nonelectrostatic molecular determinants by charge reversal mutagenesis.
Ghomashchi F; Lin Y; Hixon MS; Yu BZ; Annand R; Jain MK; Gelb MH
Biochemistry; 1998 May; 37(19):6697-710. PubMed ID: 9578553
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CD11b/CD18 expression in human neutrophils by phospholipase A2.
Jacobson PB; Schrier DJ
J Immunol; 1993 Nov; 151(10):5639-52. PubMed ID: 8228253
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of bee venom phospholipase A2 by a sesquiterpene furanoic acid marine natural product.
Grace KJ; Zavortink D; Jacobs RS
Biochem Pharmacol; 1994 Apr; 47(8):1427-34. PubMed ID: 8185650
[TBL] [Abstract][Full Text] [Related]
12. Petrosaspongiolides M-R: new potent and selective phospholipase A2 inhibitors from the New Caledonian marine sponge Petrosaspongia nigra.
Randazzo A; Debitus C; Minale L; García Pastor P; Alcaraz MJ; Payá M; Gomez-Paloma L
J Nat Prod; 1998 May; 61(5):571-5. PubMed ID: 9599251
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of venom phospholipases A2 by manoalide and manoalogue. Stoichiometry of incorporation.
Reynolds LJ; Mihelich ED; Dennis EA
J Biol Chem; 1991 Sep; 266(25):16512-7. PubMed ID: 1885583
[TBL] [Abstract][Full Text] [Related]
14. The molecular mechanism of bee venom phospholipase A2 inactivation by bolinaquinone.
Monti MC; Casapullo A; Santomauro C; D'Auria MV; Riccio R; Gomez-Paloma L
Chembiochem; 2006 Jun; 7(6):971-80. PubMed ID: 16671124
[TBL] [Abstract][Full Text] [Related]
15. Scalaradial inhibition of epidermal growth factor receptor-mediated Akt phosphorylation is independent of secretory phospholipase A2.
Xie Y; Liu L; Huang X; Guo Y; Lou L
J Pharmacol Exp Ther; 2005 Sep; 314(3):1210-7. PubMed ID: 15923342
[TBL] [Abstract][Full Text] [Related]
16. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation.
Payá M; Terencio MC; Ferrándiz ML; Alcaraz MJ
Br J Pharmacol; 1996 Apr; 117(8):1773-9. PubMed ID: 8732290
[TBL] [Abstract][Full Text] [Related]
17. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
Glaser KB; de Carvalho MS; Jacobs RS; Kernan MR; Faulkner DJ
Mol Pharmacol; 1989 Nov; 36(5):782-8. PubMed ID: 2586492
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of bee venom phospholipase A2 by manoalide. A model based on the reactivity of manoalide with amino acids and peptide sequences.
Glaser KB; Jacobs RS
Biochem Pharmacol; 1987 Jul; 36(13):2079-86. PubMed ID: 3111475
[TBL] [Abstract][Full Text] [Related]
19. The inactivation of phospholipase A2 by scalaradial: a biomimetic study by electrospray mass spectrometry.
Monti MC; Casapullo A; Riccio R; Gomez-Paloma L
Rapid Commun Mass Spectrom; 2005; 19(3):303-8. PubMed ID: 15645482
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of manoalide on secreted and intracellular phospholipases.
Bennett CF; Mong S; Clarke MA; Kruse LI; Crooke ST
Biochem Pharmacol; 1987 Mar; 36(5):733-40. PubMed ID: 3103628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
